HIV Infection, Antiretroviral Drugs, and the Vascular Endothelium

Keyphrases

• Antiviral Drugs 100%
• Comorbidity 100%
• AIDS/HIV 100%
• Human Immunodeficiency Virus Infection 100%
• Vascular Endothelium 100%
• Vascular Disease 66%
• Viral Suppression 66%
• Vascular Dysfunction 66%
• People Living with HIV (PLHIV) 66%
• Comorbid Diseases 66%
• Metabolic Disease 33%
• Antiretroviral Therapy 33%
• Antiretroviral 33%
• Malignancy 33%
• Pathophysiology 33%
• Or Injury 33%
• Cardiovascular Disease 33%
• Viral Proteins 33%
• High Prevalence 33%
• Drug Class 33%
• Virus Proteins 33%
• Combined Antiretroviral Therapy (cART) 33%
• Vascular Injury 33%
• In Vitro Study 33%
• Endothelial Cell Dysfunction 33%
• Neurological Complications 33%
• Premature Aging 33%
• Endothelial Cell Injury 33%
• Vascular Graft Infection 33%
• Neuropsychiatric Complications 33%
• Endothelial Cell Activation 33%
• Vascular Activation 33%
• People Living with Human Immunodeficiency Virus 33%

Pharmacology, Toxicology and Pharmaceutical Science

• HIV 100%
• Human Immunodeficiency Virus Infection 100%
• Injury 75%
• Comorbidity 75%
• Disease 50%
• Vascular Disease 50%
• Pathophysiology 25%
• Prevalence 25%
• Cardiovascular Disease 25%
• Viral Protein 25%
• Metabolic Disorder 25%
• Acquired Immune Deficiency Syndrome 25%
• Endothelial Dysfunction 25%
• Vasculitis 25%
• Premature Aging 25%
• Human Immunodeficiency Virus Protein 25%